DELE1 and ovarian cancer: Collectively, our results showed that the mitochondrial PHB2/OMA1/DELE1 pathway cooperated with cisplatin-induced ER stress to amplify the pro-death signals of MIM and MOM, which provided a novel mechanism for increasing the sensitivity of ovarian cancer to cisplatin (Figure 8).